IL141286A0 - Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride - Google Patents

Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Info

Publication number
IL141286A0
IL141286A0 IL14128699A IL14128699A IL141286A0 IL 141286 A0 IL141286 A0 IL 141286A0 IL 14128699 A IL14128699 A IL 14128699A IL 14128699 A IL14128699 A IL 14128699A IL 141286 A0 IL141286 A0 IL 141286A0
Authority
IL
Israel
Prior art keywords
preparation
paroxetine hydrochloride
anhydrate form
crystalline anhydrate
crystalline
Prior art date
Application number
IL14128699A
Other languages
English (en)
Original Assignee
Smithkline Beechmam Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en
Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en
Application filed by Smithkline Beechmam Plc filed Critical Smithkline Beechmam Plc
Publication of IL141286A0 publication Critical patent/IL141286A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14128699A 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride IL141286A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817196.0A GB9817196D0 (en) 1998-08-07 1998-08-07 Novel process
GBGB9828777.4A GB9828777D0 (en) 1998-12-29 1998-12-29 Novel compounds
PCT/GB1999/002592 WO2000008017A1 (en) 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Publications (1)

Publication Number Publication Date
IL141286A0 true IL141286A0 (en) 2002-03-10

Family

ID=26314179

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14128699A IL141286A0 (en) 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Country Status (24)

Country Link
EP (2) EP1100796B1 (es)
JP (1) JP2002522434A (es)
KR (1) KR20010072323A (es)
CN (1) CN1321155A (es)
AP (2) AP2001002072A0 (es)
AT (1) ATE239016T1 (es)
AU (1) AU5428999A (es)
BG (1) BG105310A (es)
BR (1) BR9912858A (es)
CA (1) CA2339857A1 (es)
DE (1) DE69907467T2 (es)
DK (1) DK1100796T3 (es)
EA (1) EA200100221A1 (es)
ES (1) ES2198940T3 (es)
HK (1) HK1038230A1 (es)
HU (1) HUP0105466A3 (es)
ID (1) ID27914A (es)
IL (1) IL141286A0 (es)
NO (1) NO20010629L (es)
PL (1) PL345885A1 (es)
PT (1) PT1100796E (es)
SK (1) SK1972001A3 (es)
TR (1) TR200100444T2 (es)
WO (1) WO2000008017A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384711A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optical resolution of a piperidine derivative
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
AU2002224322A1 (en) * 2000-11-17 2002-05-27 Eli Lilly And Company Lactam dipeptide and its use in inhibiting beta-amyloid peptiderelease
WO2004035052A1 (ja) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
CN1249686A (zh) * 1997-01-15 2000-04-05 史密丝克莱恩比彻姆有限公司 帕罗西丁制剂
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法

Also Published As

Publication number Publication date
DE69907467D1 (de) 2003-06-05
JP2002522434A (ja) 2002-07-23
ID27914A (id) 2001-05-03
CA2339857A1 (en) 2000-02-17
HUP0105466A2 (hu) 2002-05-29
SK1972001A3 (en) 2001-08-06
HK1038230A1 (en) 2002-03-08
EP1100796A1 (en) 2001-05-23
CN1321155A (zh) 2001-11-07
AP2001002072A0 (en) 2001-03-31
AP0102072A0 (en) 2001-02-06
EP1100796B1 (en) 2003-05-02
WO2000008017A1 (en) 2000-02-17
BR9912858A (pt) 2001-11-20
HUP0105466A3 (en) 2002-11-28
NO20010629D0 (no) 2001-02-06
AU5428999A (en) 2000-02-28
DE69907467T2 (de) 2004-03-11
DK1100796T3 (da) 2003-08-25
NO20010629L (no) 2001-03-20
ES2198940T3 (es) 2004-02-01
PT1100796E (pt) 2003-09-30
KR20010072323A (ko) 2001-07-31
BG105310A (en) 2001-12-29
EA200100221A1 (ru) 2001-08-27
EP1321465A2 (en) 2003-06-25
ATE239016T1 (de) 2003-05-15
PL345885A1 (en) 2002-01-14
TR200100444T2 (tr) 2001-07-23
EP1321465A3 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
SG43787A1 (en) Novel paroxetine hydrochloride anhydrate
HK1029529A1 (en) Novel process for manufacturing paroxetine solid dispersions
IL149226A0 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
HUP0202651A3 (en) Method for producing l-phenylephrine hydrochloride
GB9930430D0 (en) A method of preparing fabric softening compositions
AU1987400A (en) Process for preparation of paroxetine maleate
HK1038230A1 (en) Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
IL137684A0 (en) Salts of paroxetine
EP1185266A4 (en) AMORPHOUS FORM OF FEXOFENADINE CHLORYDRATE
IL140385A0 (en) Salts of paroxetine
HUP0004503A3 (en) Process for the preparation of paroxetine hydrochloride
AU1397800A (en) Method of producing paroxetine hydrochloride
HUP9900761A3 (en) A process for the preparation of 4-(desdimethyl-amino)-tetracyclines
AU1398500A (en) Process for the production of paroxetine hydrochloride propan-2-ol solvate
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
PL342931A1 (en) Crystalline form of paroxetine
EP1242362A4 (en) METHOD FOR PRODUCING FLUOXETINE HYDROCHLORIDE
AU6580800A (en) Process for the preparation of paroxetine hydrochloride
AU1396600A (en) Process for the preparation of paroxetine hydrochloride
LT96007A (en) Paroxetine hydrochloride anhydrate and process for preparing thereof
AU7025800A (en) Process for the preparation of 1-methyl-3-carbomethoxy-4-(4'-fluorophenyl)-piperidine
AU1398300A (en) Amine salts of paroxetine
AU740561C (en) Paroxetine hydrochloride anhydrate
AU5550900A (en) Process for the production of paroxetine hydrochloride